跳转至内容
Merck
CN

BP1141

系统适用性试验用格列美脲

British Pharmacopoeia (BP) Reference Standard

别名:

格列美脲

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C24H34N4O5S
CAS号:
分子量:
490.62
MDL编号:
UNSPSC代码:
41116107
NACRES:
NA.24

等级

pharmaceutical primary standard

形式

solid

保质期

limited shelf life, expiry date on the label

制造商/商品名称

BP

应用

pharmaceutical
pharmaceutical small molecule

格式

neat

储存温度

2-8°C

SMILES字符串

CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)C1=O

InChI

1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)/t16-,19-

InChI key

WIGIZIANZCJQQY-RUCARUNLSA-N

基因信息

正在寻找类似产品? 访问 产品对比指南

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Glimepiride for system suitability BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.
格列美脲目前用于治疗 2 型糖尿病。

生化/生理作用

格列美脲是一种有效的心肌梗死 KATP 通道阻断剂,被吡那地尔激活,IC50 值为 6.8 nM。

包装

Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他说明

Sales restrictions may apply.

象形图

Health hazard

警示用语:

Warning

危险声明

危险分类

Repr. 2

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门